What is NDC 68180-407?

68180-407 is the product NDC for Cefixime, Cefixime 200 mg/5mL powder, for suspension, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.

Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cefixime?

10 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cefixime NDC 68180-407 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68180-407Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68180-0407Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68180-407-03	6818004070368180040703	50 mL in 1 BOTTLE (68180-407-03)Marketed from Apr 24, 2015
68180-407-04	6818004070468180040704	75 mL in 1 BOTTLE (68180-407-04)Marketed from Apr 24, 2015

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cefixime
Generic name (nonproprietary): cefixime
Active ingredients: Cefixime — 200 mg/5mL
Dosage form: Powder, For suspension
Route: Oral
Labeler: Lupin Pharmaceuticals, Inc.NDC labeler code 68180
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065355
Marketing start: Apr 24, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Cephalosporins (Chemical structure)
Identifiers: Product ID 68180-407_735f86f4-369c-4f5a-adbe-7dacea2e27b4SPL ID 735f86f4-369c-4f5a-adbe-7dacea2e27b4SPL set ID 6d68dbd9-7d75-4ff1-91db-79ff8ae879ecRxCUI 309058, 409823, 419849UNII 97I1C92E55UPC 0368180423089, 0368180407034, 0368180416081, 0368180416111
Pharmacologic class: Cephalosporin Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468180040703 followed by a unit qualifier and the quantity

Package 68180-0407-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 14, 2025.

Indications (excerpt from the label)

Cefixime is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections ( 1.1 ) Otitis Media ( 1.2 ) Pharyngitis and Tonsillitis ( 1.3 ) Acute Exacerbations of Chronic Bronchitis ( 1.4 ) Uncomplicated Gonorrhea (cervical/urethral) ( 1.5 ) Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime and other antibacterial drugs, cefixime for oral suspension and cefixime capsules should be used only to treat infections that are proven or strongly suspected to be caused by bacteria…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68180-407

What is NDC 68180-407?: 68180-407 is the product NDC for Cefixime, Cefixime 200 mg/5mL powder, for suspension, listed with the FDA by Lupin Pharmaceuticals, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cefixime.
What is the active ingredient?: Cefixime.
Who is the labeler?: Lupin Pharmaceuticals, Inc., NDC labeler code 68180. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cefixime?: 10 other product NDCs are listed under this name. See all Cefixime NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cefixime NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cefixime	Cefixime 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4759	70518-4759-00
Cefixime	Cefixime 400 mg/1	CapsuleOral	Aurobindo Pharma Limited	59651-647	59651-0647-1059651-0647-50
Cefixime	Cefixime 400 mg/1	TabletOral	Rising Pharma Holdings, Inc.	64980-430	64980-0430-01
Cefixime	Cefixime 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-3221	70518-3221-0270518-3221-04
Cefixime	Cefixime 400 mg/1	CapsuleOral	Lupin Pharmaceuticals, Inc.	68180-423	68180-0423-0868180-0423-11
Cefixime	Cefixime 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-2749	70518-2749-0270518-2749-05
Cefixime	Cefixime 400 mg/1	CapsuleOral	Ascend Laboratories, LLC	67877-584	67877-0584-0167877-0584-0567877-0584-33+1 more
Cefixime	Cefixime 100 mg/5mL	Powder, For suspensionOral	Lupin Pharmaceuticals, Inc.	68180-405	68180-0405-01
Cefixime	Cefixime 100 mg/5mL	Powder, For suspensionOral	Aurobindo Pharma Limited	65862-751	65862-0751-0165862-0751-50
Cefixime	Cefixime 200 mg/5mL	Powder, For suspensionOral	Aurobindo Pharma Limited	65862-752	65862-0752-5065862-0752-75